Top

Published in:

01-12-2015 | Original paper

Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study

Authors: Danny V. Colombara, Lisa E. Manhart, Joseph J. Carter, Stephen E. Hawes, Noel S. Weiss, James P. Hughes, Matt J. Barnett, Gary E. Goodman, Jennifer S. Smith, You-Lin Qiao, Denise A. Galloway

Published in: Cancer Causes & Control | Issue 12/2015

Abstract

Purpose

To test whether infection with select human polyomaviruses (HPyV) and human papillomaviruses (HPV) is associated with incident lung cancer.

Methods

We performed a nested case–control study, testing serum from the carotene and retinol efficacy trial, conducted 1985–2005, for antibodies to Merkel cell (MCV), KI (KIV), and WU (WUV) HPyVs as well as to six high-risk and two low-risk HPV types. Incident lung cancer cases (n = 200) were frequency-matched with controls (n = 200) on age, enrollment and blood draw dates, intervention arm assignment, and the number of serum freeze/thaw cycles. Sera were tested using multiplex liquid bead microarray antibody assays. We used logistic regression to assess the association between HPyV and HPV antibodies and lung cancer.

Results

There was no evidence of a positive association between levels of MCV, KIV, or WUV antibodies and incident lung cancer (p corrected >0.10 for all trend tests; odds ratio (OR) range 0.72–1.09, p corrected >0.10 for all). There was also no evidence for a positive association between HPV 16 or 18 infection and incident lung cancer (p corrected ≥0.10 for all trend tests; OR range 0.25–2.54, p > 0.05 for all OR > 1), but the number of persons with serologic evidence of these infections was small.

Conclusions

Prior infection with any of several types of HPyV or HPV was not associated with subsequent diagnosis of lung cancer. Infection with these viruses likely does not influence a person’s risk of lung cancer in Western smoking populations.

Available only for authorised users

Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128. doi:10.1016/S0140-6736(12)61728-0 CrossRefPubMed

Moore PS, Chang Y (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10:878–889PubMedCentralCrossRefPubMed

Schulz TF (2009) Cancer and viral infections in immunocompromised individuals. Int J Cancer 125:1755–1763. doi:10.1002/ijc.24741 CrossRefPubMed

Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59–67. doi:10.1016/S0140-6736(07)61050-2 CrossRefPubMed

Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100. doi:10.1126/science.1152586 PubMedCentralCrossRefPubMed

Carter JJ, Paulson KG, Wipf GC et al (2009) Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 101:1510–1522. doi:10.1093/jnci/djp332 PubMedCentralCrossRefPubMed

Babakir-Mina M, Ciccozzi M, Lo Presti A et al (2010) Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients. J Med Virol 82:505–509. doi:10.1002/jmv.21711 CrossRefPubMed

Allander T, Andreasson K, Gupta S et al (2007) Identification of a third human polyomavirus. J Virol 81:4130–4136. doi:10.1128/JVI.00028-07 PubMedCentralCrossRefPubMed

Gaynor AM, Nissen MD, Whiley DM et al (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3:e64. doi:10.1371/journal.ppat.0030064 PubMedCentralCrossRefPubMed

10.

Helmbold P, Lahtz C, Herpel E et al (2009) Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer 45:2207–2211. doi:10.1016/j.ejca.2009.04.038 CrossRefPubMed

11.

Joh J, Jenson AB, Moore GD et al (2010) Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 89:222–226. doi:10.1016/j.yexmp.2010.08.001 CrossRefPubMed

12.

Gheit T, Muñoz JP, Levican J et al (2012) Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol 93:162–166. doi:10.1016/j.yexmp.2012.04.008 CrossRefPubMed

13.

Hashida Y, Imajoh M, Nemoto Y et al (2013) Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer. Br J Cancer 108:629–637. doi:10.1038/bjc.2012.567 PubMedCentralCrossRefPubMed

14.

Babakir-Mina M, Ciccozzi M, Campitelli L et al (2009) Identification of the novel KI Polyomavirus in paranasal and lung tissues. J Med Virol 81:558–561. doi:10.1002/jmv.21417 CrossRefPubMed

15.

Duncavage EJ, Le B, Wang D, Pfeifer JD (2009) Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol 33:1771–1777. doi:10.1097/PAS.0b013e3181ba7b73 CrossRefPubMed

16.

Teramoto S, Kaiho M, Takano Y et al (2011) Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol Immunol 55:525–530. doi:10.1111/j.1348-0421.2011.00346.x CrossRefPubMed

17.

Houben R, Grimm J, Willmes C et al (2012) Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis. J Invest Dermatol 132:254–256. doi:10.1038/jid.2011.260 CrossRefPubMed

18.

Grulich AE, Jin F, Conway EL et al (2010) Cancers attributable to human papillomavirus infection. Sex Health 7:244–252. doi:10.1071/SH10020 CrossRefPubMed

19.

Yuan H, Myers S, Wang J et al (2012) Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med 367:1220–1227. doi:10.1056/NEJMoa1203055 PubMedCentralCrossRefPubMed

20.

DiLorenzo TP, Tamsen A, Abramson AL, Steinberg BM (1992) Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol 73(Pt 2):423–428CrossRefPubMed

21.

Srinivasan M, Taioli E, Ragin CC (2009) Human papillomavirus type 16 and 18 in primary lung cancers—a meta-analysis. Carcinogenesis 30:1722–1728. doi:10.1093/carcin/bgp177 PubMedCentralCrossRefPubMed

22.

Klein F, Amin Kotb WFM, Petersen I (2009) Incidence of human papilloma virus in lung cancer. Lung Cancer 65:13–18. doi:10.1016/j.lungcan.2008.10.003 CrossRefPubMed

23.

Zhai K, Ding J, Shi H (2015) HPV and lung cancer risk: a meta-analysis. J Clin Virol 63:84–90. doi:10.1016/j.jcv.2014.09.014 CrossRefPubMed

24.

Vanner EA, Shroyer KR (2015) Comments on “HPV and lung cancer risk: a meta-analysis” [Zhai et al., J. Clin. Virol. (in press)]. J Clin Virol 63:91. doi:10.1016/j.jcv.2014.11.019

25.

Omenn GS, Goodman GE, Thornquist MD et al (1996) Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 88:1550–1559CrossRefPubMed

26.

Omenn GS, Goodman G, Thornquist M et al (1994) The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 54:2038s–2043sPubMed

27.

Goodman GE, Thornquist MD, Balmes J et al (2004) The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 96:1743–1750. doi:10.1093/jnci/djh320 CrossRefPubMed

28.

Waterboer T, Sehr P, Michael KM et al (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51:1845–1853. doi:10.1373/clinchem.2005.052381 CrossRefPubMed

29.

Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309:200–204. doi:10.1016/j.jim.2005.11.008 CrossRefPubMed

30.

Antonsson A, Green AC, Mallitt K-A et al (2010) Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol 91:1849–1853. doi:10.1099/vir.0.020115-0 CrossRefPubMed

31.

Sehr P, Zumbach K, Pawlita M (2001) A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 253:153–162CrossRefPubMed

32.

Hsieh FY, Bloch DA, Larsen MD (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623–1634CrossRefPubMed

33.

Tolstov YL, Pastrana DV, Feng H et al (2009) Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125:1250–1256. doi:10.1002/ijc.24509 PubMedCentralCrossRefPubMed

34.

Burnett-Hartman AN, Newcomb PA, Schwartz SM et al (2012) No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev 21:1599–1601. doi:10.1158/1055-9965.EPI-12-0651 PubMedCentralCrossRefPubMed

35.

Syrjänen S, Waterboer T, Sarkola M et al (2009) Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol 90:1515–1526. doi:10.1099/vir.0.007823-0 CrossRefPubMed

36.

Michael KM, Waterboer T, Sehr P et al (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4:e1000091. doi:10.1371/journal.ppat.1000091 PubMedCentralCrossRefPubMed

37.

Ernst MD (2004) Permutation Methods: a basis for exact inference. Stat Sci 19:676–685. doi:10.1214/088342304000000396 CrossRef

38.

Wilson LE, Pawlita M, Castle PE et al (2013) Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer 133:2172–2181. doi:10.1002/ijc.28215 PubMedCentralCrossRefPubMed

39.

Simen-Kapeu A, Surcel H-M, Koskela P et al (2010) Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer. Cancer Epidemiol Biomarkers Prev 19:1879–1881. doi:10.1158/1055-9965.EPI-10-0356 CrossRefPubMed

40.

Anantharaman D, Gheit T, Waterboer T et al (2014) No causal association identified for human papillomavirus infections in lung cancer. Cancer Res 74:3525–3534. doi:10.1158/0008-5472.CAN-13-3548 CrossRefPubMed

41.

Koshiol J, Rotunno M, Gillison ML et al (2011) Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 103:501–507. doi:10.1093/jnci/djr003 PubMedCentralCrossRefPubMed

42.

Syrjänen K (2012) Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res 32:3235–3250PubMed

43.

Korup S, Rietscher J, Calvignac-Spencer S et al (2013) Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS One 8:e58021. doi:10.1371/journal.pone.0058021 PubMedCentralCrossRefPubMed

44.

Schowalter RM, Pastrana DV, Pumphrey KA et al (2010) Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7:509–515. doi:10.1016/j.chom.2010.05.006 PubMedCentralCrossRefPubMed

45.

van der Meijden E, Janssens RW, Lauber C et al (2010) Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 6:e1001024. doi:10.1371/journal.ppat.1001024 PubMedCentralCrossRefPubMed

46.

Scuda N, Hofmann J, Calvignac-Spencer S et al (2011) A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol 85:4586–4590. doi:10.1128/JVI.02602-10 PubMedCentralCrossRefPubMed

47.

Siebrasse EA, Reyes A, Lim ES et al (2012) Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol 86:10321–10326. doi:10.1128/JVI.01210-12 PubMedCentralCrossRefPubMed

48.

Lim ES, Reyes A, Antonio M et al (2013) Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology 436:295–303. doi:10.1016/j.virol.2012.12.005 PubMedCentralCrossRefPubMed

49.

Yu G, Greninger AL, Isa P et al (2012) Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One 7:e49449. doi:10.1371/journal.pone.0049449 PubMedCentralCrossRefPubMed

50.

Combes J-D, Pawlita M, Waterboer T et al (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer 135:2453–2461. doi:10.1002/ijc.28888 CrossRefPubMed

51.

Smith EM, Rubenstein LM, Haugen TH et al (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012:571862. doi:10.1155/2012/571862 PubMedCentralCrossRefPubMed

Title: Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study
Authors: Danny V. Colombara
Lisa E. Manhart
Joseph J. Carter
Stephen E. Hawes
Noel S. Weiss
James P. Hughes
Matt J. Barnett
Gary E. Goodman
Jennifer S. Smith
You-Lin Qiao
Denise A. Galloway
Publication date: 01-12-2015
Publisher: Springer International Publishing
Published in: Cancer Causes & Control / Issue 12/2015
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-015-0676-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2015

Excess body weight and colorectal cancer survival: the multiethnic cohort

Association between magnesium intake and risk of colorectal cancer among postmenopausal women

Determinants of the t(14;18) translocation and their role in t(14;18)-positive follicular lymphoma

Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype

Polycyclic aromatic hydrocarbon (PAH)–DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study

PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer